Home › NDC Lookup › Ingredients › Metoclopramide › 70518-4541-00
⚪image loading
(from DailyMed)

Metoclopramide 10 mg Tablet, 40-count — NDC 70518-4541-0 (Billing 70518-4541-00)

by REMEDYREPACK INC. · 40 TABLET in 1 BOTTLE, PLASTIC

This is a package of 40 tablets of Metoclopramide 10 mg Tablet from REMEDYREPACK INC., marketed since Dec 2025 and currently FDA-listed, this package's marketing is listed to end Jun 2027. It is this product's only package size.

NDC 70518-4541-00
🏷️ FDA NDC (as labeled) 70518-4541-0 billing pads the package segment with a zero
Rx only Brand On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Oct 8, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 70518-4541-0 alone.

Record
FDA NDC Directory package listing · Human prescription drug
Code segments
70518 labeler · 4541 product · 0 package
Package marketed since
Dec 23, 2025
Package marketing ended
Jun 30, 2027
Sample package
No — commercial package
Barcode (UPC-A, from the NDC)
3 7051845410 8
FDA record last changed
Oct 8, 2026
⚠️
Other active recalls for Metoclopramide (different manufacturers) — 1 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · May 23, 2025 — Presence of foreign tablets/capsules. (Teva Pharmaceuticals USA, Inc) · FDA recall D-0473-2025
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 70518-4541-0
Product NDC 70518-4541
11-digit billing NDC 70518454100
Application # NDA017854
SPL Set ID 5b9c4cff-c1e4-1ddf-e063-6294a90a5b51
Established class (EPC) Dopamine-2 Receptor Antagonist
Mechanism of action Dopamine D2 Antagonists
DEA schedule Non-controlled
Marketing category NDA AUTHORIZED GENERIC
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2025-12-23
Marketing end 2027-06-30
Route ORAL
Dosage form TABLET
Substance METOCLOPRAMIDE HYDROCHLORIDE
TE code (Orange Book) AB · RLD · RS
Why two NDCs? The FDA registers this code as 70518-4541-0 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 70518-4541-00. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

📖 What it is MedlinePlus · NLM

Metoclopramide is used to treat gastroesophageal reflux disease (GERD; condition in which backward flow of acid from the stomach causes heartburn and injury of the esophagus) and gastroparesis (slow stomach emptying) . Metoclopramide is in a class of medications called prokinetic agents. It works by speeding the movement of food through the stomach and intestines.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • It helps the stomach and esophagus move things along. It's used for reflux that hasn't responded to usual treatment and for diabetic gastroparesis. The injection is also used for c...
  • The oral forms and Gimoti nasal spray are generally used about 30 minutes before meals and at bedtime. Follow your prescriber's directions and the label. Don't keep taking it longe...
  • Treatment is meant to be short, generally no more than 12 weeks. The longer you take it, the higher your risk of tardive dyskinesia, a movement disorder that can be permanent.
  • Restlessness, drowsiness, tiredness and weakness are most common. Some people have nausea, diarrhea, headache or dizziness. Be careful driving until you know how it affects you.
📖 Read our full Metoclopramide guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · Q2 2026 $0.0766 $3.06 / 40 tablets
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
70518-4541-00 You're viewing this Main listing 40 TABLET in 1 BOTTLE, PLASTIC 2025-12-23 Jun 30, 2027 Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Metoclopramide 10 mg 00093-2203-01 Teva 100 tablets $0.044 AB Availability likely —
Metoclopramide 10 mg 50228-0233-01 ScieGen 100 tablets $0.044 AB Availability likely —
Metoclopramide 10 mg 51079-0888-20 Mylan 100 tablets $0.044 AB Availability likely —
Metoclopramide 10 mg 60687-0631-01 American 100 tablets $0.044 AB Availability likely —
Metoclopramide 10 mg 62559-0296-01 ANI 100 tablets $0.044 AB Availability likely —
Metoclopramide 10 mg 83980-0011-01 Ipca 100 tablets $0.044 AB Availability likely —
Metoclopramide 10 mg 00615-8285-30 NCS 30 tablets — AB Discontinued —
Metoclopramide 10 mg 42291-0596-90 AvKARE 90 tablets — AB FDA listed —
Metoclopramide 10 mg 48433-0067-20 Safecor 100 tablets — AB FDA listed —
Metoclopramide 10 mg 50090-0132-00 A-S 30 tablets — AB FDA listed —
Metoclopramide 10 mg 51655-0240-52 Northwind 30 tablets — AB FDA listed —
Reglan 10 mg 62559-0166-01 ANI 100 tablets — AB FDA listed —
Metoclopramide 10 mg 63187-0235-30 Proficient 30 tablets — AB FDA listed —
Metoclopramide 10 mg 63629-8745-01 Bryant 500 tablets — AB FDA listed —
Metoclopramide 10 mg 66267-0286-20 NuCare 20 tablets — AB FDA listed —
Metoclopramide 10 mg 66267-0827-04 NuCare 4 tablets — AB FDA listed —
Metoclopramide 10 mg 67046-0581-03 Coupler 30 tablets — AB FDA listed —
Metoclopramide 10 mg 68788-7930-03 Preferred 30 tablets — AB FDA listed —
Metoclopramide 10 mg 70518-0669-00 REMEDYREPACK 30 tablets — AB FDA listed —
Metoclopramide 10 mg 70518-1193-00 REMEDYREPACK 60 tablets — AB Discontinued —
Metoclopramide 10 mgthis 70518-4541-00 REMEDYREPACK 40 tablets — AB FDA listed —
Metoclopramide 10 mg 71335-0362-01 Bryant 30 tablets — AB FDA listed —
Metoclopramide 10 mg 67296-2309-02 Redpharm 15 tablets — AB FDA listed —
Metoclopramide 10 mg 53401-0027-01 Aphena 1 tablet — AB FDA listed —
About this product: this is an authorized generic — the brand-name product marketed without its brand name. Other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2025
On the market since
Dec 2025
📍
2026
Currently FDA-listed
1 year listed
🔓
·
Generic versions listed
see equivalents
✅Generic appears available

FDA-approved generic versions are listed, and recent pricing/market data suggests they may be available — see Therapeutic equivalents.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Metoclopramide inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerREMEDYREPACK INC.
Application holderANI PHARMACEUTICALS INC
FDA applicationNDA017854 (NDA AUTHORIZED GENERIC)
Labeler code70518
First marketedDec 2025
Product typeHuman Prescription Drug
Portfolio1,529 products on file

More NDCs from REMEDYREPACK INC. labeler code 70518

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

Full prescribing information FDA SPL

The complete FDA label for this product — the official prescribing information, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
📄 FDA label
📄 FDA label 19 words ▾

No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

About this NDC listing & data coverage

Finished prescription product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data ✓ Available
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page it is currently marketed — but REMEDYREPACK INC. has reported a marketing end date of 2027-06-30, after which this package is expected to stop being marketed. The directory data on this page refreshes weekly.
Who lists this product with the FDA?
REMEDYREPACK INC. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as a prescription product, so it is dispensed under a prescriber's order. Your pharmacist can tell you whether any over-the-counter forms of the same medication exist.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 70518-4540-00 · REMEDYREPACK 70518-4542-00 · REMEDYREPACK →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.